Incyte Reaches CMS Agreement on Medicaid Pricing for Jakafi and Jakafi XR
Filed with the SEC on · Summarized by InvestorsBot
Incyte said on August 31, 2026, that it entered an agreement with the Centers for Medicare & Medicaid Services to give state Medicaid programs access to Jakafi and Jakafi XR at prices aligned with those in a defined group of other advanced industrialized nations. The company expects to avoid certain future CMS pricing mandates, including the proposed GUARD and GLOBE models, and said the agreement will not affect its 2026 financial guidance or materially affect its future financial outlook.